Literature DB >> 16883219

[Prestarium in patients with arterial hypertension and ischemic heart disease (or risk factors) -- safe achievement of target blood pressure level (the PREMIERA study)].

Iu A Karpov, S A Shal'nova, A D Deev.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16883219

Source DB:  PubMed          Journal:  Kardiologiia        ISSN： 0022-9040            Impact factor:   0.395


× No keyword cloud information.
  2 in total

1.  Antihypertensive efficacy of perindopril 5-10 mg/day in primary health care: an open-label, prospective, observational study.

Authors:  Dan-Dominic Ionescu
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

2.  Perindopril for control of blood pressure in patients with hypertension and other cardiovascular risk factors: an open-label, observational, multicentre, general practice-based study.

Authors:  Richard Ian Ogilvie; Sanjiv Anand; Pierre Roy; Selwyn De Souza
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.